Showing results (491-500 of 539) with videos related to

Sort By:
Pageof 54
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|June 14, 2023
[Genomics of next generation sequencing in pediatric B-acute lymphoblastic leukemia and its impact on minimal residual disease]Y Y Gao, Y J Jia, B Q Qi, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|November 4, 2016
[Analysis of clinical characteristics and prognosis of non-severe aplastic anemia children with chromosomal abnormalities]S Zhu, W B An, Y Wan, et al.
European Journal of Neurology|February 2, 2013
Restless legs syndrome in end-stage renal disease: a multicenter study in TaiwanC-H Lin, V-C Wu, W-Y Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[Heterogeneity and clonal evolution in pediatric ETV6-RUNX1(+) acute lymphoblastic leukemia by quantitative multigene fluorescence in situ hybridization]L Zhang, L P Hu, X M Liu, et al.
European Journal of Neurology|August 22, 2014
Restless legs syndrome is associated with cardio/cerebrovascular events and mortality in end-stage renal diseaseC-H Lin, H-N Sy, H-W Chang, et al.
European Journal of Neurology|January 18, 2014
Association of candidate genetic variants with restless legs syndrome in end stage renal disease: a multicenter case-control study in TaiwanC H Lin, M L Chen, V C Wu, et al.
Zhonghua Yi Xue Za Zhi|July 9, 2024
[Clinical features and prognostic factors of advanced myelodysplastic syndromes in children]C M Liu, Y L Chen, X C Wang, et al.
British Journal of Cancer|March 1, 2002
Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancerC H Yang, C M Tsai, L S Wang, et al.
Zhonghua Yi Xue Za Zhi|July 9, 2024
[The safety and efficacy of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia in children]X L Li, B B Zhao, Y Wan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2015
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trialM Schuler, J C-H Yang, K Park, et al.
Pageof 54